Industry & Business

Diaceutics Raises €4.3 Million to Support Global Expansion

 Breaking News
  • Pioneering Proteomics Researcher and Entrepreneur Receives the NovaUCD 2018 Innovation Award The NovaUCD 2018 Innovation Award has been presented to University College Dublin’s (UCD) Professor Stephen Pennington (pictured), a global leader in proteomics (the study of proteins) research and innovation. The Award was presented to him in recognition of his commitment and success in protein biomarker research, undertaken during the last 15-years at the UCD School [...]...
  • National Manufacturing & Supply Chain Conference & Exhibition 2019 – Thursday, January 17th – Citywest Hotel, Dublin Approximately 3,000 people from all over Ireland are expected to visit the 2019 National Manufacturing & Supply Chain Conference & Exhibition at the Citywest Hotel, Dublin on Thursday, January 17th, making the event the largest gathering of the manufacturing and supply chain community in the country. Now in its sixth year, the National Manufacturing and Supply [...]...
  • DIT Launches New MSc in Transport and Mobility Over 250 million journeys were taken by passengers on Irish public transport services in 2017, and with the population set to increase, this number is likely to continue growing in the coming years. Dublin Institute of Technology (DIT) has launched Ireland’s first ever MSc programme in Transport and Mobility designed to equip graduates with the knowledge [...]...
  • Swedencare Expanding Operations in Ireland Swedencare AB, which acquired the Nutri-Science brand, product range and manufacturing facility in Waterford in November 2016, has moved into new, larger premises, which was purchased earlier this year, in the city which it has redeveloped to more than double its capacity and secure and expand its workforce presence in Waterford. NutriScience was originally an Irish [...]...
  • PREM Group Acquires Majority Stake in Rate Wise International hotel and hospitality management company PREM Group has taken a significant equity stake in Rate Wise. Rate Wise was originally founded in Dublin by software developer Niall O’Meara and quickly became a leading rate management tool working with 76 hotel and serviced apartment clients across 9 countries including Ireland, the UK, Belgium, Netherlands, Hong [...]...

Diaceutics Raises €4.3 Million to Support Global Expansion

Diaceutics Raises €4.3 Million to Support Global Expansion
April 09
11:53 2018

Irish company, Diaceutics, the diagnostic commercialisation company that improves patient outcomes via better diagnostic testing, has raised €4.3 million in new mezzanine financing from two partners, WhiteRock Capital Partners and Silicon Valley Bank. The money will be used to support the organisation’s continued global expansion.

Specifically, Diaceutics will use the funding to invest in the data analytics services that it provides to pharmaceutical clients and continue to expand its global laboratory network. The company will also look to grow the internal team of experts to deliver data-driven insights designed to improve diagnostic testing that benefits patients.

A recent analysis of Diaceutics testing data revealed that, globally, over 150,000 cancer patients are missing out on potentially life-saving therapies due to substandard diagnostic testing. By investing in expanding their data sources, and continuing to build expertise in oncology and general medicine disease areas, Diaceutics will further enable pharmaceutical clients to more effectively commercialise targeted medications. The results will deliver enhanced diagnostics and more effective treatment for patients.

Over the last three years, the company has experienced revenue growth of 60% year-on-year. In 2017, it achieved revenue of $10 million and aims to reach $40 million revenue by the end of 2020. Moreover, the organisation currently works with 31 out of the world’s top 35 pharmaceutical companies. It recently, announced a partnership with Intel and Lenovo to leverage artificial intelligence in a machine learning environment to further improve the diagnosis and treatment of patients.

By working with WhiteRock Capital Partners, which works with businesses with export potential, and Silicon Valley Bank, which enables companies across the areas of technology, healthcare and data to access emerging markets across the globe, Diaceutics will continue its accelerated growth path and increase its international reach.

Speaking about the new partnerships, Peter Keeling, CEO, Diaceutics, said: “Our focus has always been, and will continue to be, helping patients benefit from better testing. Silicon Valley Bank and WhiteRock Capital Partners have been hugely supportive of this vision and we are delighted to have them as partners at the table.

“We need to continually broaden our global data capabilities and insights; this mezzanine financing allows us to keep pace with our data collection and protection infrastructure while expanding globally. Furthermore, we are eager to continue diversifying beyond our expertise in oncology into general medicine areas, and provide our pharmaceutical clients with invaluable insights that help them ensure patients who can benefit from these precision drugs are indeed receiving them.”

Andrew Gowdy, Senior Portfolio Manager, WhiteRock Capital Partners, commented: “Diaceutics is paving the way when it comes to precision medicine, transforming how patients are diagnosed and treated. Partnering with a company that is revolutionising healthcare and expanding at an incredible rate is very exciting.”

These sentiments were echoed by Clive Lennox, Director of Irish Business Development, Silicon Valley Bank, who said: “Our aim is to work with innovators who are solving real world problems and Diaceutics certainly delivers those solutions. We’re committed to supporting the burgeoning Irish technology market and we are thrilled to be involved with such a dynamic organisation, as it takes the next step in its journey and expands out into a wider range of markets.”

CAPTION:

Pictured at the announcement are (L-R): Andrew Gowdy, Senior Portfolio Manager, WhiteRock Capital Partners; Peter Keeling, CEO, Diaceutics; and Clive Lennox, Director of Irish Business Development, Silicon Valley Bank. Mandatory Credit ©Press Eye/Darren Kidd

About Author

admin

admin

Related Articles

New Subscriber





Subscribe Here



Advertisements



















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4